Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis - Université de Rennes Accéder directement au contenu
Article Dans Une Revue ESC Heart Failure Année : 2021

Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis

Résumé

Various clinical presentations of the 2019 coronavirus disease (COVID-19) have been described, including post-infectious acute and fulminant myocarditis. Here, we describe the case of a young patient admitted for COVID-19-associated post-infectious fulminant myocarditis. Despite optimal pharmacologic management, haemodynamic status worsened requiring support by veno-arterial extracorporeal membrane oxygenation. Emergent heart transplantation was required at Day 11 given the absence of cardiac function improvement. The diagnosis of post-infectious COVID-19-associated myocarditis was made from both pathologic examination of the explanted heart and positive SARS-CoV-2 serology.

Dates et versions

hal-03222671 , version 1 (10-05-2021)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Baptiste Gaudriot, Alexandre Mansour, Vincent Thibault, Mathieu Lederlin, Aurélie Cauchois, et al.. Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis. ESC Heart Failure, 2021, 8 (4), pp.2625-2630. ⟨10.1002/ehf2.13326⟩. ⟨hal-03222671⟩
84 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More